(Q24293040)

positive regulation of calcineurin-NFAT signaling cascade

GOA release 2020-03-11

1 reference

LIM and cysteine-rich domains 1

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

Zhou-Yan Bian

1

0 references

He Huang

2

0 references

Hong Jiang

3

0 references

Di-Fei Shen

4

0 references

Ling Yan

5

0 references

Li-Hua Zhu

6

0 references

Lang Wang

7

0 references

Feng Cao

8

0 references

Chen Liu

9

0 references

Qi-Zhu Tang

10

0 references

Hongliang Li

Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy

11

0 references

language of work or name

English

0 references

publication date

February 2010

0 references

published in

Hypertension

0 references

volume

55

0 references

issue

2

0 references

page(s)

257-63

0 references

cites work

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Identification of a novel LIM domain gene, LMCD1, and chromosomal localization in human and mouse

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Dysferlin, dystrophy, and dilatative cardiomyopathy

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

The LIM domain is a modular protein-binding interface

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Sculpting heart valves with NFATc and VEGF.

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

LIM domains: multiple roles as adapters and functional modifiers in protein interactions

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Novel pharmacotherapies to abrogate postinfarction ventricular remodeling

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

NFAT proteins: key regulators of T-cell development and function

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

The LIM domain: from the cytoskeleton to the nucleus

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Regulation of cardiac hypertrophy by intracellular signalling pathways

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Molecular dissection of a LIM domain

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

LMCD1/Dyxin is a novel transcriptional cofactor that restricts GATA6 function by inhibiting DNA binding

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

The fuzzy logic of physiological cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

Protein kinase cascades in the regulation of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1161%2FHYPERTENSIONAHA.109.135665

7 January 2021

10.1161/HYPERTENSIONAHA.109.135665

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20026769

1 reference

Consolidated OpenCitations Corpus – April 2017